Category Archives: Neuroscience

BioXcel Therapeutics to Present at Two Upcoming Healthcare Investor Conferences – BioSpace

NEW HAVEN, Conn., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioXcel Inc. (BTI or Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced that Dr. Vimal Mehta, Founder and Chief Executive Officer of BTI, will present at two upcoming healthcare investor conferences.

Conference Presentation Details:

Event: Cowen and Co. 40th Annual Health Care ConferenceDate/Time: Wednesday, March 4, 2020 at 10:00 a.m. Eastern TimeLocation: Boston, MA

Event: Barclays Global Healthcare ConferenceDate/Time: Tuesday, March 10, 2020 at 3:50 p.m. Eastern TimeLocation: Miami, FL

Live webcasts from the Cowen and Barclays conference presentations and any accompanying presentation materials that will be discussed will be accessible through the Investors section of the Company's website at http://www.bioxceltherapeutics.com. Following the conference, the webcast will be archived on the BioXcel Therapeutics, Inc. website for at least 30 days.

About BioXcel Therapeutics, Inc.:

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BTI's two most advanced clinical development programs are BXCL501, an investigational sublingual thin film formulation in development for acute treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immunity activator in development for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer in combination with other immuno-oncology agents. For more information, please visit http://www.bioxceltherapeutics.com.

Contact Information:

BioXcel Therapeutics, Inc.www.bioxceltherapeutics.com

Investor Relations:John Grazianojgraziano@troutgroup.com 1.646.378.2942

Media:Julia Deutschjdeutsch@troutgroup.com 1.646.378.2967

The rest is here:
BioXcel Therapeutics to Present at Two Upcoming Healthcare Investor Conferences - BioSpace

Columbia University Names Julie Mehretu Artist-in-Residence Focusing on Brain Science & the Arts at Tadias Magazine – Tadias Magazine

Artist Julie Mehretu is one of three trailblazers in visual arts, music and creative writing who have been named by Columbia University's Zuckerman Mind Brain Behavior Institute as the 2020 Artists-in-Residence. (Photo: Julie Mehretu in New York Nathan Bajar/The New York Times/Redux/Eyevine)

Columbia University

Columbias Zuckerman Institute Announces Three Artists-in-Residence, Fostering Connections Between Brain Science and the Arts

Year-long program embeds award-winning painter, jazz musician and author with scientists studying the mind, the brain and behavior

NEW YORK A trio of pioneers in the fields of visual arts, jazz and literature have been named as the 2020 Artists-in-Residence at Columbias Mortimer B. Zuckerman Mind Brain Behavior Institute. Artist Julie Mehretu, musician Miguel Zenn and author Nicole Krauss will spend the next year collaborating with scientists at the Institute in an endeavor that immerses artists in the cutting-edge field of neuroscience.

Science and the arts have much to learn from each other, and the Artist-in-Residence program provides a concrete way to bridge these disciplines. I cannot think of a better group of artists to enrich our scientific community, said Rui Costa, DVM, PhD, Director and CEO of Columbias Zuckerman Institute. By building bridges between neuroscience and creative expression, while also strengthening our links to our neighboring communities, these artists-in-residence will inspire scientists, artists and the public to think creatively about their work, how each of us, using our own medium and expertise, can provide a positive impact on society.

During their residencies, each artist will work with Zuckerman Institute researchers and scientists across the University, as well as engage with the neighboring communities in Upper Manhattan and the Bronx. The artists-in-residence, each hosted by a Zuckerman Institute faculty member, will develop, participate and lead a variety of events, from formal lectures, seminars and performances, to informal workshops, collaborations and conversations. By the end of their residencies, each artist as well as the scientists and members of the wider Columbia and neighboring communities stands to benefit from access to new knowledge and perspectives

More about the 2020 Artists-in-Residence:

Julie Mehretu, Alan Kanzer Artist-in-Residence

Julie Mehretu is a world-renowned painter, born in Addis Ababa, Ethiopia, who lives and works in New York City and Berlin. Mehretu is a MacArthur Fellow and recipient of the US Department of State Medal of Arts Award. She has shown her work extensively in international and national solo and group exhibitions and is represented in public and private collections around the world. Projects include completing two large-scale paintings for the San Francisco Museum of Modern Arts Evelyn and Walter Haas, Jr. Atrium in September 2017. Recent exhibitions include Venice Biennale and a mid-career survey at the Los Angeles County Museum of Art, which travels to The Whitney Museum of American Art in New York in 2020.

Read the full article at columbia.edu

Related:

Julie Mehretus Mid-Career Survey at LA County Museum of Art

Join the conversation on Twitter and Facebook.

More:
Columbia University Names Julie Mehretu Artist-in-Residence Focusing on Brain Science & the Arts at Tadias Magazine - Tadias Magazine

New iTHRIV Projects Approved, LG expands to Floyd – Roanoker

Four research projects will benefit by $200,000 from the Clinical and Translational Science Award (CTSA) partnership, which features resources from Carilion Clinic, Virginia Tech, the University of Virginiaand Inova Health System. The funding will go to projects through the Pilot Translational and Clinical Studies Program.

The funding, broken into segments, benefits multi-institutional teams of scientists, physicians, and engineers who will explore new machine learning approaches to cancer cell recognition, shoulder surgery recovery recommendations, a potential new treatment for depressionand what triggers an inflammatory throat disease.

The awarded pilot projects include:

A study of ultrasound and depression, among the most prevalent and debilitating psychiatric illnesses and a leading cause of disability in the U.S. Researchers will be led by Sarah Clinton of Virginia Techs School of Neuroscience, and Wynn Legon of the Department of Neurosurgery at the University of Virginia School of Medicine.

Driving after rotator cuff surgery will be the focus of Peter Apel of Virginia Tech Carilion School of Medicine and Carilion Clinic and Miguel Perez director of the Center for Data Reduction and Analysis Support at the Virginia Tech Transportation Institute.

A new approach to cancer cell recognition will be the focus of Nathan Swami, a computer engineer at the University of Virginia, Todd Bauer of UVa, and Eva Schmelz from Techs Department of Human Nutrition.

A study of painful esophagus inflammation will be led by Irving Coy Allen of the Virginia-Maryland College of Veterinary Medicine, and Emily McGowan at UVA Health.

iTHIRV is a cross-state translational research institute. Partner sites include Carilion Clinic, Virginia Tech, the University of Virginiaand Inova Health System.

LewisGale Physicians will open a new primary care practice in Floyd March 3. Jared March, a doctor of osteopathic medicine (DO) and a resident of Floyd will will provide care at the new location.

March specializes in internal medicine and has experience in managing chronic diseases, including working with and educating patients on lifestyle changes to improve overall health.

The new office is onFranklin Pike. For more information call 540-745-5060.

About the Writer:

Dan Smith is an award-winning Roanoke-based writer/author/photographer and a member of the Virginia Communications Hall of Fame (Class of 2010). His blog, fromtheeditr.com, is widely read and he has authored seven books, including the novel CLOG! He is founding editor of a Roanoke-based business magazine and a former Virginia Small Business Journalist of the Year (2005).

See the rest here:
New iTHRIV Projects Approved, LG expands to Floyd - Roanoker

Assessment Changes Open Up Neuroscience Research to People With Intellectual Disabilities – Technology Networks

The NIH Toolbox Cognitive Battery an assessment of cognitive functioning for adults and children participating in neuroscience research can be adapted to people with intellectual disabilities by modifying some test components and making accommodations for the test-takers disabilities, according to researchers funded by the National Institutes of Health. The adaptations ensure that the battery can be used to assess the cognitive ability of people with intellectual disabilities who have a mental age of 5 years and above, providing objective measures that could be used in a wide variety of studies.The research team, led by David Hessl, Ph.D., of the University of California Davis Medical Center, published their findings in Neurology. The work was funded by NIHs Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Center for Advancing Translational Sciences, as well as the Administration for Community Living.

The battery is administered on a computer tablet and measures memory, vocabulary, reading and executive functioning, which includes skills such as the ability to shift from one thought to another, pay attention and control impulses. The researchers adapted the battery by reducing the complexity of the instructions and including developmentally appropriate starting points. They also developed a structured manual to guide test administrators.

The researchers validated the battery and its modifications by assessing 242 people ages 6 through 25 with fragile X syndrome, Down syndrome or other disabilities. They found that the battery produced reliable and valid results for those with a mental age of 5 years and above. The authors called for additional research to adapt the battery to people with lower mental ages and to older adults with intellectual disability who may be experiencing cognitive decline or dementia.ReferenceShields et al. (2020) Validation of the NIH Toolbox Cognitive Battery in intellectual disability. Neurology. DOI: https://doi.org/10.1212/WNL.0000000000009131

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read the rest here:
Assessment Changes Open Up Neuroscience Research to People With Intellectual Disabilities - Technology Networks

New endowment promotes study of the brain – Yale Daily News

Giovanna Truong

A new donation by Yale alumni will promote neuroscience research at the School of Medicine.

James Lawrence 74 and Mary Lawrence MPH 98 created a new endowment for brain research in honor of their son, Thomas Kingsley Lawrence, who would have graduated in the class of 2019 but took his own life after a long battle with bipolar disorder. The endowment will be used to create the Thomas Kingsley Lawrence 19 Program in Brain Research and to establish the Lawrence Family Professorship in Brain Research.

This is a remarkable and generous gift that will directly facilitate the research of the faculty member who holds the professorship, said Michael Crair, the newly-appointed vice provost for research at the School of Medicine. The research program is expected to be multifaceted, with some attention paid to basic mechanisms of disease, as well as the development of novel strategies for disease prevention or therapeutic treatments.

The programs logistics will be overseen by the deans office at the School of Medicine. The school will soon appoint a director for the program. Director of the Mood Disorders Research Program Hilary Blumberg told the News that the donation comes at a critical time for the field.

Research in this area is critically needed, [it] could literally save lives, Blumberg emphasized. The Mood Disorders Research Program focuses on understanding the brain circuitry of bipolar disorder, suicide and translating basic neurobiology into treatment and prevention in adolescents.

The Mood Disorders Research Program is one of many initiatives that will benefit from the new endowment. The program will spearhead an initiative to bring faculty and students together in an interdisciplinary approach to studying mood disorders, with a focus on bipolar disorder and suicide. Blumbergs lab focuses on the relationship between brain structure and the development of suicidal tendencies.

We have found that there is an important link between bipolar disorder in adolescence and the neurobiology of suicidal behaviors, said Blumberg. Thats important because we can then develop targets for prevention for people at risk.

Blumberg said she is also hopeful that these findings will help with treatment. This would include using brain scanning to see how sleep and other daily rhythms affect brain circuitry and suicide risk.

According to Crair, the endowment will also include funding for a professorship, which will permit the faculty involved to oversee a program that catalyzes the research of junior faculty in the area and the development of new therapies or diagnostics for brain disorders.

In a statement to the News, Dean Nancy Brown stated that the School of Medicine is very excited about this major gift from Jim and Mary Lawrence in memory of their son.

The statement also noted that the program will provide support for early-career investigators and teams who undertake high-risk, high-reward research initiatives in the field. The School of Medicine aims to use the donation to fund innovative research that would not otherwise happen.

Our hope is that the knowledge generated will lead to novel prevention strategies, diagnostics, and therapeutics, wrote Brown.

In 2023, the Yale-New Haven Hospital will open a new neuroscience building for both treatment and research.

Beatriz Horta | beatriz.horta@yale.edu

More:
New endowment promotes study of the brain - Yale Daily News

Mouse Study Suggests Hitting the Immune "Reset Button" May Help Brain Injury Recovery – Technology Networks

Targeting overactive immune cells and dampening their chronic neurotoxic effects may offer new therapeutic strategies for traumatic brain injury (TBI), according to new preclinical research in mice, which has been published in the Journal of Neuroscience.

The collaborative research, which involved scientists from Trinity College Dublin and the University of Maryland School of Medicine, Baltimore, USA, also suggests that the impact of TBI on brain degeneration may be modifiable a relatively long time after the injury was sustained - something at odds with current thinking.

Triggered by trauma, microglia - the brain's immune cells - morph into an inflammatory state, which helps to protect the brain. However, long-term inflammation after TBI may contribute to neurological degeneration and cognitive declines similar to those observed in TBI-associated neurodegenerative diseases, such as chronic traumatic encephalopathy and Alzheimer's disease.

The scientists involved in the new study found that highly delayed targeting of chronic inflammation pathways may be a very effective therapeutic strategy for TBI.

One month after a TBI, the team inhibited a particular receptor microglia need to survive. The inhibition killed 95% of the mice microglia cells. However, the cells bounced back to normal levels once the inhibition ends.

The researchers then stopped the inhibition after one week and let the mice recover for a few months. They found that the inhibition essentially "reset" the mice's microglia: the new cells were in a more normal, less inflammatory state. The mice recovered better than the mice that didn't receive treatment, showing less brain damage, fewer neuron deaths, and better motor and cognitive performance.

David Loane, Research assistant professor in Trinity's School of Biochemistry and Immunology, said:

"These preclinical studies suggest that the consequences of TBI on brain degeneration and related neurological impairment may be modifiable quite a long time after injury by targeting inflammation pathways, which is a finding at odds with widely accepted views about head injury."

"The exciting thing is the possibility that we may one day be able to minimise brain degeneration and neurological impairment in people who have suffered a TBI. It will of course always be incredibly important to act quickly whenever someone suffers a TBI, but our findings suggest targeting inflammation pathways further down the treatment line may make a major difference to long-term brain health and recovery."

Dr Loane has recently established a state-of-the-art, preclinical research laboratory in Trinity to study the neuroimmunology of TBI and related dementias. His work is supported by an SFI President of Ireland Future Research Leaders Award and the National Institutes of Health (USA).

Reference: Henry, R. J., Ritzel, R. M., Barrett, J. P., Doran, S. J., Jiao, Y., Leach, J. B., Szeto, G. L., Wu, J., Stoica, B. A., Faden, A. I., & Loane, D. J. (2020). Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits. Journal of Neuroscience. https://doi.org/10.1523/JNEUROSCI.2402-19.2020

See the article here:
Mouse Study Suggests Hitting the Immune "Reset Button" May Help Brain Injury Recovery - Technology Networks

New discoveries in neuroscience show what’s right and wrong with AI – Best gaming pro

Two separate research, one by UK-based synthetic intelligence lab DeepMind and the opposite by researchers in Germany and Greece, show the fascinating relations between AI and neuroscience.

As most scientists will let you know,we are still decades awayfrom constructing synthetic normal intelligence, machines that may remedy issues as effectively as people. On the trail to creating normal AI, the human mind, arguably essentially the most complicated creation of nature, is the most effective information we now have.

Advances in neuroscience, the research of nervous techniques, present attention-grabbing insights into how the mind works, a key element for creating higher AI techniques. Reciprocally, the event of higher AI techniques may help drive neuroscience ahead and additional unlock the secrets and techniques of the mind.

For example,convolutional neural networks (CNN), one of many key contributors to current advances in synthetic intelligence, are largely impressed by neuroscience analysis on the visible cortex. However, neuroscientists leverage AI algorithms tostudy millions of signals from the brainand discover patterns that might have gone. The 2 fields are intently associated and their synergies produce very attention-grabbing outcomes.

Current discoveries in neuroscience present what were doing proper in AI, and what weve acquired improper.

Reinforcement studying is a sizzling space of AI analysis

A current research by researchers at DeepMind proves that AI analysis (at the very least a part of it) is headed in the fitting path.

Because of neuroscience, we all know that one of many primary mechanisms by way of which people and animals be taught is rewards and punishments. Constructive outcomes encourage us to repeat sure duties (do sports activities, research for exams, and so forth.) whereas adverse outcomes detract us from repeating errors (contact a sizzling range).

The reward and punishment mechanism is greatest identified by the experiments of Russian physiologistIvan Pavlov, who skilled canines to count on meals every time they hear a bell. We additionally know that dopamine, a neurotransmitter chemical produced within the midbrain, performs an incredible function in regulating the reward features of the mind.

Learn: [Chess grandmaster Gary Kasparov predicts AI will disrupt 96 percent of all jobs]

Reinforcement learning, one of many hottest areas of synthetic intelligence analysis, has been roughly long-established after the reward/punishment mechanism of the mind. In RL, an AI agent is ready to discover an issue area and take a look at completely different actions. For every motion it performs, the agent receives a numerical reward or penalty. By way of large trial and error and by inspecting the result of its actions, the AI agent develops a mathematical mannequin optimized to maximise rewards and avoiding penalties. (In actuality, its a bit extra sophisticated and entails coping with exploration and exploitation and different challenges.)

Extra lately, AI researchers have been specializing in distributional reinforcement studying to create higher fashions. The essential thought behind distributional RL is to make use of a number of elements to foretell rewards and punishments in a spectrum of optimistic and pessimistic methods. Distributional reinforcement studying has been pivotal in creating AI brokers which are extra resilient to adjustments of their environments.

The brand new analysis, collectively completed by Harvard College and DeepMind and printed inNaturefinal week, has discovered properties within the mind of mice which are similar to these of distributional reinforcement studying. The AI researchers measured dopamine firing charges within the mind to look at the variance in reward prediction charges of organic neurons.

Curiously, the identical optimism and pessimism mechanism that AI scientists had programmed in distributional reinforcement studying fashions was discovered within the nervous system of mice. In abstract, we discovered that dopamine neurons within the mind had been every tuned to completely different ranges of pessimism or optimism, DeepMinds researchers wrote in ablog postprinted on the AI labs web site. In synthetic reinforcement studying techniques, this various tuning creates a richer coaching sign that vastly speeds studying in neural networks, and we speculate that the mind may use it for a similar motive.

What makes this discovering particular is that whereas AI analysis normally takes inspiration from neuroscience discovery, on this case, neuroscience analysis has validated AI discoveries. It provides us elevated confidence that AI analysis is heading in the right direction since this algorithm is already being utilized in essentially the most clever entity were conscious of: the mind, the researchers write.

It would additionally lay the groundwork for additional analysis in neuroscience, which is able to, in flip, profit the sector of AI.

Supply: Flickr (Penn State)

Whereas DeepMinds new findings confirmed the work completed in AI reinforcement studying analysis, one other analysis by scientists in Berlin, this timepublished inSciencein early January, proves that among the basic assumptions we made concerning the mind are fairly improper.

The final perception concerning the construction of the mind is that neurons, the essential element of the nervous system are easy integrators that calculate the weighted sum of their inputs.Artificial neural networks, a well-liked kind ofmachine learningalgorithm, have been designed based mostly on this perception.

Alone, a synthetic neuron performs a quite simple operation. It takes a number of inputs, multiplies them by predefined weights, sums them and runs them by way of an activation perform. However when connecting hundreds and thousands and thousands (and billions) of synthetic neurons in a number of layers, you acquire a really versatile mathematical perform that may remedy complicated issues similar todetecting objects in imagesor transcribing speech.

The construction of a synthetic neuron, the essential element of synthetic neural networks (supply: Wikipedia)

Multi-layered networks of synthetic neurons, typically known as deep neural networks, are the principle drive behind thedeep learningrevolution previously decade.

However the normal notion of organic neurons being dumb calculators of primary math is overly simplistic. The current findings of the German researchers, which had been later corroborated by neuroscientists at a lab in Greece, proved that single neurons can carry out XOR operations, a premise that was rejected by AI pioneers similar to Marvin Minsky and Seymour Papert.

Whereas not all neurons have this functionality, the implications of the discovering are vital. For example, itd imply single neuron may comprise a deep community inside itself. Konrad Kording, a computational neuroscientist on the College of Pennsylvania who was not concerned within the analysis,toldQuanta Magazinethat the discovering might imply a single neuron could possibly compute actually complicated features. For instance, itd, by itself, be capable to acknowledge an object.

What does this imply for synthetic intelligence analysis? On the very least, it implies that we have to rethink our modeling of neurons. It would spur analysis in new synthetic neuron buildings and networks with several types of neurons. Possibly itd assist free us from the entice of getting to constructextremely large neural networks and datasetsto resolve quite simple issues.

The entire recreationto provide you with the way you get sensible cognition out of dumb neuronsis likely to be improper, cognitive scientist Gary Marcus, who additionally spoke toQuanta, stated on this regard.

This story is republished from TechTalks, the weblog that explores how expertise is fixing issues and creating new ones. Like them on Fb right here and observe them down right here:

See the rest here:
New discoveries in neuroscience show what's right and wrong with AI - Best gaming pro

NeurologyLive Launches Updates to the MRI Protocol and Clinical Guidelines for MS Video Series Along With the Consortium of Multiple Sclerosis Centers…

CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, presents its most recent Peer Exchange panel discussion in partnership with the Consortium of Multiple Sclerosis Centers (CMSC), Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group. The video series welcomes several experts in the field of neuroscience and radiology who discuss changes to the magnetic resonance imaging (MRI) protocol and clinical guidelines for multiple sclerosis (MS) and strategies for implementation.

The CMSC is proud to be an ongoing resource for all those affected by multiple sclerosis: the healthcare team and the patients and families who receive expert care, state-of-the-art education, and access to cutting-edge research, said June Halper, M.S.N., APN-C, MSCN, FAAN, chief executive officer of the CMSC.

This panel features five distinguished experts:

Its important that the neurology community be aware of changes to imaging and treatment protocols for MS, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the parent company of NeurologyLive. NeurologyLive is proud to partner with the CMSC to help disseminate this important information to our audience of healthcare professionals.

This Peer Exchange series begins with segments on the proposed changes to the MRI protocol and clinical guidelines. The experts will then discuss experiences with implementation and the importance of collaboration across clinical, payor, and patient groups before talking about CMSCs action plan.

Those attending the 2020 ACTRIMS Forum, February 27-29, 2020 in West Palm Beach, Florida can visit Booth #115 to learn more about the Peer Exchange and receive a complimentary copy of the NeurologyLive February 2020 journal, featuring an editorial by Drs. Traboulsee and Li.

For more information and to view the video series, click here.

About NeurologyLive

A multimedia platform for health care professionals treating neurological diseases, NeurologyLive delivers direct access to practice-changing news and expert insights directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep disorders and stroke. The NeurologyLive platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive platform also connects visitors with the most up-to-date clinical trial results, Food and Drug Administration approvals, practice-changing research and expert insights. NeurologyLive is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

See more here:
NeurologyLive Launches Updates to the MRI Protocol and Clinical Guidelines for MS Video Series Along With the Consortium of Multiple Sclerosis Centers...

9th International Conference on Neurology and Neuroscience – Third Force News

From 10:00 on28th September 2020to06:00 on29th September 2020

Holiday Inn Edinburgh, 132 Corstorphine Rd EH12 6UA

Cost: 299-799

Neuroscience Summit 2020 feels proud to announce the onset of the 9th International Conference on Neurology and Neuroscience at Edinburgh, Scotland slated to hold from Sep 28-29, 2020. We have chosen a venue that guarantees a successful technical conference amid the culture and fantastic scenery of Edinburgh. The theme of the conference Explore Contemporary advancements in Neurology and Neuroscience records the collaborative spirit of the event which will be both an educational and scientific event.

Different thematic sessions of Neuroscience Summit 2020 will showcase important scientific advances, foster discussions and hopes to inspire participants from a wide array of themes to initiate collaborations within and across the advancement of Neurology, Neuroscience, CNS, Dementia and Alzheimers Disease, Neurophysiology, Neurogenetics, Neuropathology, Neuroimmunology, Neurosurgery and other areas.

Neuroscience Summit 2020 conference is no exception and brings together neurology researchers, essential specialists, professors, students, business delegates from around the globe to discuss the latest advances in this vibrant and constantly evolving field of Neurology and Neuroscience.

We hope that this conference will challenge and inspire you, and result in deciphering knowledge, collaborations, and friendships, despite a stimulating program you will be able to enjoy the exotic and vibrant atmosphere of Edinburgh.

Read more:
9th International Conference on Neurology and Neuroscience - Third Force News

CWT Partners With Timeshifter To Offer Jet Lag Solution For Traveling Employees – Hospitality Net

CWT, the B2B4E travel management platform, announces partnership with Timeshifter - The Jet Lag App. Timeshifter gives business travelers the ability to create their own personalized jet lag avoidance plans based on sleep pattern, chronotype*, itinerary, and personal preferences - such as pre-travel adjustment, or the use of melatonin for even faster adaptation.

"As a frequent business traveler, I know the jet lag routine all too well. I tend to be tired, awake, and hungry at the wrong time, and it can be difficult to recover from a trip," said Patrice Simon, CWT's Vice President of New Product Development. "We are thrilled to offer an innovative solution that empowers traveling employees with personalized jet lag plans to increase their productivity during business meetings abroad."

Jet lag is a very common culprit of efficient job performance, family disruption, and good health while traveling across multiple time zones, and 93% of passengers traveling on long-haul flights said they struggle with jet lag, according to a study by Conde Nast Traveler. Timeshifter is founded on real sleep and circadian neuroscience. Based on 63,607 questionnaires collected from travelers using Timeshifter, only 3.62% struggled with jet lag when the advice is followed.

Timeshifter is developed with Associate Professor at Harvard Medical School, Dr. Steven Lockley. Dr. Lockley has worked for more than a decade applying circadian science to NASA astronauts to alleviate their jet lag and improve sleep and alertness when training overseas as well as helping to shift their sleep rhythms prior to shuttle launches.

Timeshifter is available to CWT clients around the world that want to include a jet lag solution in their travel program.

*A person's chronotype is the propensity for the individual to sleep at a particular time during a 24-hour period.

Timeshifter - The Jet Lag App - is developed with world-renowned scientists, based on the latest research in sleep and circadian neuroscience. The same technology used by astronauts and elite athletes to perform at their best, is now available to you. With Timeshifter, you can get personalized jet lag plans based on your sleep pattern, chronotype, itinerary, and optional preferences such as pre-travel adjustment or the use of melatonin for even faster adaptation. Timeshifter incorporates a real-world Practicality Filter, ensuring that the advice is realistic and easy to follow; there is also a unique Quick Turnaround feature for business travelers who want to be at their best during short business trips that are not long enough to allow full adjustment. An intuitive notification system provides the simple yet powerful advice, even while in-flight.

CWT is a Business-to-Business-for-Employees (B2B4E) travel management platform. Companies and governments rely on us to keep their people connected - anywhere, anytime, anyhow - and across six continents, we provide their employees with innovative technology and an efficient, safe and secure travel experience. Every single day, we look after enough travelers to fill more than 100,000 hotel rooms, while our meetings and events division handles more than 100 events every 24 hours. Engage with us via Facebook, LinkedIn, Podcast and Twitter.

See the rest here:
CWT Partners With Timeshifter To Offer Jet Lag Solution For Traveling Employees - Hospitality Net